CRIS Current Research Information System

PALAZZINI, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.769
AS - Asia 3.714
EU - Europa 3.368
AF - Africa 304
SA - Sud America 272
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.438
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.721
SG - Singapore 1.177
CN - Cina 1.003
IT - Italia 844
GB - Regno Unito 760
VN - Vietnam 740
DE - Germania 400
HK - Hong Kong 350
SE - Svezia 284
UA - Ucraina 205
BR - Brasile 186
IE - Irlanda 179
IN - India 173
FR - Francia 163
RU - Federazione Russa 161
CI - Costa d'Avorio 113
NL - Olanda 113
KR - Corea 72
TG - Togo 72
ZA - Sudafrica 71
EE - Estonia 59
JO - Giordania 48
FI - Finlandia 46
JP - Giappone 45
AR - Argentina 34
CA - Canada 34
BG - Bulgaria 31
ID - Indonesia 24
AT - Austria 23
BE - Belgio 21
SC - Seychelles 21
CH - Svizzera 18
IR - Iran 18
PL - Polonia 17
EC - Ecuador 15
CO - Colombia 12
NG - Nigeria 12
BD - Bangladesh 11
TR - Turchia 10
PK - Pakistan 9
MX - Messico 8
AU - Australia 7
ES - Italia 7
PY - Paraguay 7
CL - Cile 6
GR - Grecia 6
IQ - Iraq 6
LT - Lituania 6
PH - Filippine 5
UZ - Uzbekistan 5
VE - Venezuela 5
DK - Danimarca 4
LB - Libano 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HR - Croazia 3
MK - Macedonia 3
MY - Malesia 3
UY - Uruguay 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
KE - Kenya 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
TN - Tunisia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
CD - Congo 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MT - Malta 1
MW - Malawi 1
SN - Senegal 1
SV - El Salvador 1
TH - Thailandia 1
TZ - Tanzania 1
UG - Uganda 1
Totale 12.438
Salva come PNG Salva come JPEG
Città #
Singapore 742
Southend 677
Chandler 513
Fairfield 501
Ashburn 479
Hong Kong 349
Santa Clara 274
Wilmington 246
Woodbridge 240
Dong Ket 197
Houston 188
Beijing 185
Seattle 181
Princeton 180
Dublin 178
Cambridge 172
Ann Arbor 156
Hefei 156
Bologna 122
Boardman 114
Abidjan 113
Ho Chi Minh City 93
Jacksonville 93
Hanoi 88
Milan 84
Padova 78
Nanjing 74
Westminster 74
Lomé 72
Seoul 68
Turin 63
Los Angeles 60
Berlin 50
Amman 48
Buffalo 47
Tokyo 42
Jinan 39
Shenyang 39
San Diego 33
Medford 30
New York 29
Saint Petersburg 29
Sofia 29
Hebei 27
Helsinki 27
Redondo Beach 27
Jiaxing 26
Rome 26
Guangzhou 25
Dallas 24
Changsha 22
Munich 22
Nanchang 22
Brussels 21
Des Moines 20
São Paulo 20
Bengaluru 18
Mülheim 18
Shanghai 18
Dearborn 16
Yubileyny 16
Zhengzhou 16
Falls Church 15
Florence 15
Haiphong 15
Hangzhou 15
Olalla 14
Vienna 14
Chicago 13
Tianjin 13
Toronto 13
Amsterdam 12
Falkenstein 12
Jakarta 12
London 12
Redmond 12
Abeokuta 11
Bern 11
Mahé 11
Nuremberg 11
Taizhou 11
Warsaw 11
Bremen 10
Chengdu 10
Da Nang 10
Ningbo 10
Turku 10
Brooklyn 9
Genoa 9
Lappeenranta 9
Monmouth Junction 9
Norwalk 9
Paris 9
Redwood City 9
Ardabil 8
Boston 8
Cernusco sul Naviglio 8
Council Bluffs 8
Montreal 8
Ninh Bình 8
Totale 8.050
Salva come PNG Salva come JPEG
Nome #
A new CT-score as index of hemodynamic changes in patients with chronic thromboembolic pulmonary hypertension 238
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 230
Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy? 229
Complicanze del cateterismo cardiaco destro in pazienti con ipertensione polmonare precapillare di grado severo. 224
Il test acuto di vasoreattività nei pazienti con ipertensione arteriosa polmonare. 215
Lung neovascularity in pulmonary arterial hypertension associated with congenital heart defects and idiopathic pulmonary arterial hypertension: study of 198 patients 212
Combining bosentan and sildenafil in pulmonary arterial hypertension patients failing monotherapy: Real-world insights 203
A meta-analysis of randomized controlled trials in pulmonary arterial hypertension 199
A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension 199
Pulmonary Arterial Hypertension associated to connective tissue diseases 197
Effetti emodinamici e funzionali dell'epoprostenolo in associazione agli antagonisti recettoriali dell'endotelina e agli inibitori delle fosfodiesterasi-5 197
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 197
Aiming at the appropriate target for the treatment of pulmonary hypertension due to left heart disease 180
Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes 177
Regressione delle alterazioni elettrocardiografiche indicative di ipertrofia ventricolare destra nei pazienti con ipertensione arteriosa polmonare. 170
Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration 170
Andamento clinico, emodinamico e dei livelli plasmatici dell’NT-pro BNP in pazienti con ipertensione polmonare precapillare 166
Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. 166
BMPR2 mutations and survival in pulmonary arterial hypertension: An individual participant data meta-analysis 162
Genere femminile e ipertensione arteriosa polmonare: una relazione complessa Female gender and pulmonary arterial hypertension: a complex relationship 162
Current therapeutic approaches to pulmonary arterial hypertension. 155
Anticoagulant treatment in patients with pulmonary arterial hypertension associated with systemic sclerosis: More shadows than lights 155
Effetti del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare idiopatica, associata e cuore polmonare cronico tromboembolico. 153
Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension 150
Significato prognostico dell'aerea del rigurgito tricuspidalico nei pazienti con ipertensione arteriosa polmonare idiopatica trattati secondo le attuali linee guida. 149
Effetti clinici ed emodinamici del trattamento con sildenafil nei pazienti con ipertensione arteriosa polmonare. 148
Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension. 147
Challenges in pulmonary hypertension: Managing the unexpected 146
Pulmonary hypertension in primary Sjogren's syndrome: report of a case and review of the literature. 144
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 143
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. 141
A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines 141
Sildenafil therapy in patients with porto-pulmonary hypertension 138
Cardiologia pediatrica. Problematiche cliniche 138
Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study 137
Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger's Syndrome. 136
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 136
Pulmonary arterial hypertension. Part II: Medical and surgical treatment 134
Effetti del sildenafil in soggetti con cuore polmonare cronico tromboembolico 134
Pulmonary veno-occlusive disease: the role of CT 134
Confronto tra antagonista recettoriali selettivi e non selettivi dell'endotelina nel trattamento dell'ipertensione arteriosa polmonare. 132
Rare causes of pulmonary hypertension. Spectrum of radiological findings and review of the literature 132
Tadalafil in idiopathic or heritable pulmonary arterial hypertension (PAH) compared to PAH associated with connective tissue disease 130
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism 130
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry 128
Pulmonary Arterial Hypertension Associated with Portal Hypertension and HIV Infection: Comparative Characteristics and Prognostic Predictors 126
The difficult diagnosis of pulmonary vascular disease in heart failure 125
Reverse remodelling of ECG changes in idiopathic pulmonary arterial hypertension patients responders to chronic treatment with calcium channel blockers 124
Pulmonary hypertension and systemic sclerosis: the role of highresolution computed tomography. 123
Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects 123
Effetti a lungo termine del trattamento con bosentan sulla capacità funzionale e sui parametri emodinamici nei pazienti con ipertensione arteriosa polmonare. 122
Chronic thromboembolic pulmonary disease 120
Current medical therapies in pulmonary arterial hypertension 119
Exercise training in pulmonary hypertension: improving performance but waiting for outcome 119
Long-term therapeutic outcomes in pulmonary arterial hypertension 118
Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension 117
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 117
Effetti a lungo termine del trattamento con sildenafil nei pazienti affetti da ipertensione arteriosa polmonare associata a cardiopatie congenite con shunt 116
L. Negro, M. Zavatta, C. Bachetti, E. Beciani, M. Palazzini, S. Romanazzi, E. Leci, M. Grossi, A. Marinelli, S. Gambetti, A. Manes, N. Galiè, A. Branzi 115
Conventional Medical Therapies in the treatment of pulmonary hypertension 114
Evidence for Kaposi's sarcoma-associated herpes virus infection in patients with idiopathic pulmonary arterial hypertension: a case series and review of the literature 114
Pharmacological impact on right ventricular remodelling in pulmonary arterial hypertension 114
[Treatment goals of pulmonary hypertension]. 112
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial 112
Left Main Coronary Artery Extrinsic Compression in Patients With Pulmonary Arterial Hypertension: Technical Insights and Long-Term Clinical Outcomes After Stenting 111
Pulmonary hypertension due to left heart disease 111
GPs meet rare lung disorders task force factsheet: Pulmonary arterial hypertension 110
Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. 109
The burden of comorbidities in pulmonary arterial hypertension 109
Pulmonary hypertension 108
Pulmonary vascular disease due to left heart disease: How to achieve a more accurate approach beyond the haemodynamic phenotype: Reply 108
Long-term efficacy and safety of sildenafil in precapillary pulmonary hypertension 108
Epidemiology of patients referred to a specialised pulmonary hypertension center 107
Left ventricular dimensions in pulmonary arterial hypertension: haemodynamic and exercise correlations 107
Experience with inheritable pulmonary arterial hypertension in a specialised center 104
Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed. 102
Pulmonary artery intimal sarcoma. Problems in the differential diagnosis. I sarcomi intimali dell'arteria polmonare. Problemi di diagnosi differenziale 100
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism 98
Pulmonary arterial hypertension: Guidelines and unmet clinical needs 97
Thrombolysis in high-risk patients with acute pulmonary embolism: underuse of a life-saving treatment in the real-world setting 95
Prognostic role of haemodynamics at follow-up in patients with pulmonary arterial hypertension: a challenge to current European Society of Cardiology/European Respiratory Society risk tools 95
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function 94
Ipertensione polmonare: Necessità di chiarezza tra definizione emodinamica-fisiopatologica, stima ecocardiografica e diagnosi clinica finale. Pulmonary hypertension and the relationships between hemodynamic-pathophysiologic definitions, echocardiographic estimate and final clinical diagnosis: clarification is needed. 94
Treatment goals of pulmonary hypertension. 94
Extracorporeal cardiopulmonary support in acute high-risk pulmonary embolism: Still waiting for solid evidence 94
Balloon pulmonary angioplasty after pulmonary thromboendarterectomy 92
Pulmonary Hypertension: Lessons from Adults 91
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trial 86
Long-term outcomes after pulmonary endarterectomy 86
Left main coronary artery extrinsic compression by enlarged pulmonary artery in patients with pulmonary arterial hypertension 75
Progressi nel trattamento delle malattie della circolazione polmonare 71
Comparison of different treatment strategies in patients with chronic thromboembolic pulmonary hypertension: a single centre real-world experience 59
Chronic Thromboembolic Pulmonary Hypertension and Chronic ThromboembolicPulmonary Disease (CTEPD): Clinical and Interventional Perspective 58
Metrics for Success of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension 52
Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease 50
Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2 49
Confirmation of survival prediction based on 2022 ESC/ERS pulmonary hypertension guidelines new haemodynamic thresholds 43
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension 40
Extrinsic Compression Of The Left Main Coronary Artery By Enlarged Pulmonary Artery In Patients With Pulmonary Arterial Hypertension 38
Phenotyping of patients with mild pulmonary hypertension 9
Totale 12.708
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021860 0 0 0 0 0 100 24 58 121 54 47 456
2021/20221.603 139 80 106 134 123 88 43 100 62 118 303 307
2022/20232.045 202 275 94 266 94 171 62 115 416 96 146 108
2023/2024411 36 78 30 43 29 56 23 12 12 33 34 25
2024/20252.346 79 384 259 162 396 105 166 89 42 151 82 431
2025/20262.399 413 463 398 321 582 222 0 0 0 0 0 0
Totale 12.711